Navigation Links
Osteotech Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/4/2010

arian subsidiary instituted in December 2008 and removed in late July 2009; and lower domestic unit sales volume.  This decline was partially offset by the revenue received in conjunction with the Company’s aforementioned license agreement.

Net income for the fourth quarter ended December 31, 2009 was $890,000, or $0.05 per diluted share, compared with net loss of $409,000, or $0.02 per share, for the fourth quarter of 2008.  Net loss for the full year ended December 31, 2009 was $4.0 million, or $0.22 per share, compared with net income of $2.2 million, or $0.12 per diluted share, for 2008.  The net loss in 2009 is primarily due to the Company’s anticipated reductions in service revenue and the resulting lower gross margins.  Net loss for 2009 was partially offset by the $2.3 million in profit that the Company’s agreement to license certain tissue processing technology contributed to net income.

Guidance

Bas
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
2. Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
3. Osteotechs MagniFuse(TM) Technology Used in First U.S. Surgery
4. Osteotech Reports Third Quarter 2009 Financial Results
5. Osteotech Highlights Three Procedure-Specific MagniFuse(TM) Bone Grafting Products at the NASS 2009 Annual Meeting
6. Osteotech Announces Preliminary Fourth Quarter 2009 Revenue
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. Spherix Reports Second Quarter Earnings
9. Tapestry Reports Second Quarter 2007 Results
10. Callisto Reports on Second-Quarter 2007 Milestones
11. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  Decision Resources Group ... sclerosis (MS) patients currently treated with Biogen ... ever experienced flushing and/or gastrointestinal events while ... are currently experiencing these side effects, signifying ... medical management of such events. In the ...
(Date:7/22/2014)... 22, 2014 BiologicTx ® today announced ... 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s proprietary ... July 9 at the Miami Transplant Institute, located at ... Kidney Paired Donation (KPD) is ... for kidney transplant with one another due to incompatible ...
(Date:7/22/2014)... SCHOFIELD, Wis. , July 22, 2014 /PRNewswire/ ... and marketer of over-the-counter (OTC) medicinal and healthcare ... corporate sponsor of Operation Troop Aid. ... said Russell Mitchell , CEO and Chairman ... men and women in combat zones experience migraines ...
Breaking Medicine Technology:Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 2PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 3
... Md., April 11, 2011 Vanda Pharmaceuticals Inc. ... Novartis Pharmaceuticals Corporation, an affiliate of Vanda,s sublicensor ... to evaluate the long-acting injectable (or depot) formulation ... study that will evaluate the safety and pharmacokinetic ...
... 11, 2011 PAREXEL International Corporation (NASDAQ: ... provider, and the Parenteral Drug Association (PDA) ... Putting Theory into Practice, written to help companies ... is being placed on biopharmaceutical companies to be accountable ...
Cached Medicine Technology:Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 2Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 3PAREXEL Expert Serves as Lead Author and Editor of Definitive Resource on Quality by Design (QbD), Aimed at Maximizing Product Quality and Speeding Treatments to Market 2PAREXEL Expert Serves as Lead Author and Editor of Definitive Resource on Quality by Design (QbD), Aimed at Maximizing Product Quality and Speeding Treatments to Market 3PAREXEL Expert Serves as Lead Author and Editor of Definitive Resource on Quality by Design (QbD), Aimed at Maximizing Product Quality and Speeding Treatments to Market 4
(Date:7/22/2014)... -- Autoimmune disorders may share certain pathogenic mechanisms with ... University (GW) researcher Linda Kusner, Ph.D. , published ... This paradigm shifting work shows that the very same ... also expressed in cells that produce autoimmune diseases. ... Neurology at the GW School of Medicine and Health ...
(Date:7/22/2014)... Latin American Conference on Lung Cancer (LALCA 2014) will ... Peru. , Lung Cancer is still the leading cause ... Building on the success of the previous conferences in ... will discuss the science and advances in the treatment ... and Latin America in particular. , With tobacco being ...
(Date:7/22/2014)... 2014 Ticket Down is a reliable ... at Fedex Field in Landover, MD. There has never been ... of international soccer. After the success of the American national soccer ... alive and well. One way that fans of the world’s sport ... with the 2014 Guinness International Champions Cup. The tournament will kick ...
(Date:7/22/2014)... Angeles, CA (PRWEB) July 22, 2014 ... the way in providing resources, educational tools and recognition ... tell the stories of prevention, treatment and recovery. On ... BLACK BOX will spotlight some of these resources with ... Health Services Administration helpline and treatment website at the ...
(Date:7/22/2014)... July 22, 2014 The market for ... past few years, owing to novel medical indications created ... in the aging societies where physical appearance is extremely ... one player, current competitors, new companies and technologies are ... biosimilar BoNTs will put the price of 1st-gen products ...
Breaking Medicine News(10 mins):Health News:New research finds pathogenic connection between autoimmune disorders and cancer 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4
... Retinal snapshots could help identify with precision people at ... They say their technique is cheap enough to be ... caused by brain cell death due to bleeding from ... year in the Asia alone. , , ...
... a molecule which may harm the brain areas involved in ... disease - the doctor has to rely on the clinical ... a chemical called dopamine - which controls muscle activity - ... slowly die as the condition progresses. What kills these cells?// ...
... meat, cheese and whole milk may be at increased ... stomach. The rates of two types of cancer--gastric cardia ... past 30 years. To investigate potential links between these ... and dietary factors, Dr. Susan T. Mayne from Yale ...
... that cells exposed to high doses of iron are more responsive ... oxygen by red blood cells and iron deficiency is a relatively ... with a poor diet. That is why many breakfast cereals are ... this important mineral.// ,But too much iron might be ...
... bad for health. ,It seems that smokers have a much ... disease in their blood. The discovery could help explain why ... than non-smokers. ,Paraoxonase is a enzyme which helps ... vessels. A team of Swiss researchers examined 367 people with ...
... blood fats, unless it is combined with moderate ... heart disease risk by lowering levels of cholesterol, ... a low-fat diet is often a high-carbohydrate diet ... And it's becoming evident that a high-carbohydrate diet ...
Cached Medicine News:Health News:All the more bad, 2
Baby Weitlaner retractor, blunt, 4"....
Daubenspeck sharp curette, 8....
MRI curette, 8.5" overall length....
9.5" overall length, 4.5" handle....
Medicine Products: